Indian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs in the coming months. Approximately fifteen companies are expected to enter the primary market, with fertility and women’s health segments particularly in focus.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets